Lenalidomide

• Description:

  Lenalidomide (initially known as CC-5013 and marketed as Revlimid? by Celgene) is a derivative of thalidomide introduced in 2004.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  259.26

• Molecular Formula:

  C13H13N3O3

• Notes:

  Research use only, not for human use.

• Receptor:

  TNF-α

• CAS Number:

  191732-72-6